Optimal
>60 L/min for low to medium-high resistance DPIs
>30 L/min for high-resistance DPIs
Impaired
Cognitive: Dementia, intellectual disabilities, memory loss, trouble completing tasks, and/or difficulty following instructions
Manual: Impaired fine motor activities, tremor, reduced handgrip strength, arthritis
Recommendations:
Suboptimal <60 L/min for low to medium-high resistance DPIs
<30 L/min for high-resistance DPIs
DPI
SMI
Suboptimal
Optimal
Peak Inspiratory Flow
IMPAIRED
NORMAL
Cognitive Function and/or Manual Dexterity
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
pMDI + Valved Holding Chamber
Recommendations:
Select an option above by clicking on it
PARI COMPACT2 with PARI LC SPRINT COMPACT
pMDI + Valved Holding Chamber
Recommendations:
Select an option above by clicking on it
PARICOMPACT2 with PARI LC SPRINT COMPACT
pMDI + Valved Holding Chamber
Recommendations:
SMI
DPI
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Recommendations:
Select an option above by clicking on it
Select an option above by clicking on it
Select an option above by clicking on it
SMI
pMDI
Recommendations:
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
Select an option above by clicking on it
pMDI
Use in COPD patients who feel congested and have sticky mucus, or have mucus plugs present on CT scan. Nebulised saline thins sticky mucus and helps patients to clear their airways. GOLD guideline recommends oscillating PEP therapy for mucus mobilisation. Mucus clearance treatments may improve symptoms and quality of life in COPD patients.
Disclaimer: The proposals of the device are based on the recommendations of international guidelines. However, the interactive Device Selection Tool does not replace the expertise of the treating healthcare professional.
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
Select the optimal device for inhalation therapy for your patient by moving your mouse to the area of the chart that best describes your patient's level of cognitive function and/or manual dexterity, as well as their peak inspiratory flow. Click on the ⓘ fields for some guidance. Once you have made your selection, click on the relevant device for more details.
PARI Interactive Device Selection Tool for COPD
PARICOMPACT2 with PARI LC SPRINT COMPACT
PARICOMPACT2 with PARI LC SPRINT COMPACT
Find out how PARI products can help COPD patients – COPD-PARI
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
INTERNATIONAL
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider A VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs • Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
Click for a demonstration of the PARI interactive device selection tool
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider A VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs • Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider A VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs • Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
Click for a demonstration of the PARI interactive device selection tool
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Use in COPD patients who feel congested and have sticky mucus, or have mucus plugs present on CT scan. Nebulised saline thins sticky mucus and helps patients to clear their airways. GOLD guideline recommends oscillating PEP therapy for mucus mobilisation. Mucus clearance treatments may improve symptoms and quality of life in COPD patients.
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Recommendations:
Suboptimal
Optimal
Peak Inspiratory Flow
IMPAIRED
NORMAL
Cognitive Function and/or Manual Dexterity
Optimal
>60 L/min for low to medium-high resistance DPIs
>30 L/min for high-resistance DPIs
Suboptimal <60 L/min for low to medium-high resistance DPIs
<30 L/min for high-resistance DPIs
Impaired
Cognitive: Dementia, intellectual disabilities, memory loss, trouble completing tasks, and/or difficulty following instructions
Manual: Impaired fine motor activities, tremor, reduced handgrip strength, arthritis
UK
UK
INTERNATIONAL
Click for a demonstration of the PARI interactive device selection tool
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Nebuliser e.g. PARI BOY Pro with PARI LC SPRINT
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Nebuliser e.g. PARI BOY Pro with PARI LC SPRINT
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Nebuliser e.g. PARI BOY Pro with PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy • According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly or those who prefer nebulisers over other hand-held devices. • Consider maintenance nebuliser therapy if long-acting bronchodilators (LABA and LAMA), inhaled corticosteroid (ICS), or dual phosphodiesterase inhibitor (PDE3/ PDE4) solutions are available in your country.
pMDI + valved holding chamber e.g. PARI Health CHAMBER
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs
• Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
pMDI + valved holding chamber e.g. PARI Health CHAMBER
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Recommendations:
Suboptimal
Optimal
Peak Inspiratory Flow
IMPAIRED
NORMAL
Cognitive Function and/or Manual Dexterity
Optimal
>60 L/min for low to medium-high resistance DPIs
>30 L/min for high-resistance DPIs
Suboptimal <60 L/min for low to medium-high resistance DPIs
<30 L/min for high-resistance DPIs
Impaired
Cognitive: Dementia, intellectual disabilities, memory loss, trouble completing tasks, and/or difficulty following instructions
Manual: Impaired fine motor activities, tremor, reduced handgrip strength, arthritis
UK
INTERNATIONAL
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs
• Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs
• Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
pMDI + valved holding chamber e.g. PARI Health CHAMBER
Nebuliser e.g. PARI BOY Pro with PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy • According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly or those who prefer nebulisers over other hand-held devices. • Consider maintenance nebuliser therapy if long-acting bronchodilators (LABA and LAMA), inhaled corticosteroid (ICS), or dual phosphodiesterase inhibitor (PDE3/ PDE4) solutions are available in your country.
Find out how PARI products can help COPD patients – COPD-PARI
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy • According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly or those who prefer nebulisers over other hand-held devices. • Consider maintenance nebuliser therapy if long-acting bronchodilators (LABA and LAMA), inhaled corticosteroid (ICS), or dual phosphodiesterase inhibitor (PDE3/ PDE4) solutions are available in your country.
Find out how PARI products can help COPD patients – COPD-PARI
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy • According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly or those who prefer nebulisers over other hand-held devices. • Consider maintenance nebuliser therapy if long-acting bronchodilators (LABA and LAMA), inhaled corticosteroid (ICS), or dual phosphodiesterase inhibitor (PDE3/ PDE4) solutions are available in your country.
CHINA
CHINA
CHINA
UK
INTERNATIONAL
CHINA
Click for a demonstration of the PARI interactive device selection tool
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Use in COPD patients who feel congested and have sticky mucus, or have mucus plugs present on CT scan. Nebulised saline thins sticky mucus and helps patients to clear their airways. GOLD guideline recommends oscillating PEP therapy for mucus mobilisation. Mucus clearance treatments may improve symptoms and quality of life in COPD patients.
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Recommendations:
Suboptimal
Optimal
Peak Inspiratory Flow
IMPAIRED
NORMAL
Cognitive Function and/or Manual Dexterity
Optimal
>60 L/min for low to medium-high resistance DPIs
>30 L/min for high-resistance DPIs
Suboptimal <60 L/min for low to medium-high resistance DPIs
<30 L/min for high-resistance DPIs
Impaired
Cognitive: Dementia, intellectual disabilities, memory loss, trouble completing tasks, and/or difficulty following instructions
Manual: Impaired fine motor activities, tremor, reduced handgrip strength, arthritis
UK
INTERNATIONAL
CHINA
NORDICS
NORDICS
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System